Concepedia

James D. Reimann

JD

Statistics

Publications

12

Citations

4K

H-Index

12

Active since

1997

Affiliations

Indiana University – Purdue University Indianapolis(Current)

Cancer Research Foundation

Pharmacyclics (United States)

University of California, San Francisco

Stanford University

James D. Reimann is an author at Indiana University – Purdue University Indianapolis specializing in medicine, hypersensitivity, and immunology.

Publications per year

1997–2011

12

Publications

12

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Kathy D. Miller, Linnea Chap, Frankie A. Holmes et al. · Journal of Clinical Oncology · 2005 · 1.3K citations · Full text

, , +17

The Effect of an Anti-IgE Monoclonal Antibody on the Early- and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjects

John V. Fahy, Hannah Fleming, Hofer Wong et al. · American Journal of Respiratory and Critical Care Medicine · 1997 · 715 citations

, , +16

Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody

Henry Milgrom, Robert B. Fick, John Q. Su et al. · New England Journal of Medicine · 1999 · 707 citations · Full text

, , +15

Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★

Thomas B. Casale, William W. Busse, Craig LaForce et al. · Journal of Allergy and Clinical Immunology · 1997 · 327 citations

, , +10

Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial

Kenneth A. Ault, Christopher P Cannon, Jane Mitchell et al. · Journal of the American College of Cardiology · 1999 · 250 citations

, , +16

1–5 of 12